NDC 71225-120

VIVIMUSTA

Bendamustine Hydrochloride

VIVIMUSTA is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Slayback Pharma Llc. The primary component is Bendamustine Hydrochloride.

• Product ID: 71225-120_b3833b56-d432-479f-b2b0-a07ae1d2c799
• NDC: 71225-120
• Product Type: Human Prescription Drug
• Proprietary Name: VIVIMUSTA
• Generic Name: Bendamustine Hydrochloride
• Dosage Form: Injection
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2022-12-07
• Marketing Category: NDA /
• Application Number: NDA212209
• Labeler Name: Slayback Pharma LLC
• Substance Name: BENDAMUSTINE HYDROCHLORIDE
• Active Ingredient Strength: 25 mg/mL
• Pharm Classes: Alkylating Activity [MoA], Alkylating Drug [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 71225-120-01

1 VIAL, MULTI-DOSE in 1 CARTON (71225-120-01) > 4 mL in 1 VIAL, MULTI-DOSE

• Marketing Start Date: 2022-12-07
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "VIVIMUSTA" or generic name "Bendamustine Hydrochloride"

NDC	Brand Name	Generic Name
71225-120	VIVIMUSTA	BENDAMUSTINE HYDROCHLORIDE
42367-521	BELRAPZO	bendamustine hydrochloride
10019-079	BENDAMUSTINE HYDROCHLORIDE	bendamustine hydrochloride
16729-250	bendamustine hydrochloride	bendamustine hydrochloride
16729-251	bendamustine hydrochloride	bendamustine hydrochloride
42367-520	BENDAMUSTINE HYDROCHLORIDE	bendamustine hydrochloride
63459-348	Bendeka	bendamustine hydrochloride
63459-390	TREANDA	Bendamustine Hydrochloride
63459-391	TREANDA	Bendamustine Hydrochloride